Chimeron Bio
Signal active
Organization
Contact Information
Overview
Chimeron Bio develops an agent for personalized cancer gene therapy. The company focuses on discovering and developing personalized immunotherapeutics that will revolutionize the treatment of cancer.
The company was founded in 2015 and is headquartered in Philadelphia, Pennsylvania.
About
Industries
Biotechnology, Health Care, Therapeutics
Founded
2015
Employees
1-10
Headquarters locations
Philadelphia, Pennsylvania, United States, North America
Social
Profile Resume
Chimeron Bio headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $41.2M in funding across 36 round(s). With a team of 1-10 employees, Chimeron Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Chimeron Bio, raised $845.0K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
0
Lead Investors
0
Total Funding Amount
$1.1M
Details
2
Chimeron Bio has raised a total of $1.1M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Seed | 300.0K | ||
| 2016 | Seed | 845.0K |
Investors
Chimeron Bio is funded by 2 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Chimeron Bio | - | FUNDING ROUND - Chimeron Bio | undefined |
| Dreavent Capital | - | FUNDING ROUND - Dreavent Capital | undefined |
Recent Activity
News
Jun 19, 2024
The Business Journals - Food and Drug Administration
News
Oct 12, 2023
Next-Generation RNA Therapeutics and Vaccines Surge: Promising Modalities and Clinical Trials Fueling Growth in ...
News
Jun 09, 2022
Google Patent - Self-amplifying rna-based vlp vaccines
News
Jun 09, 2022
Google Patent - Peptide vlp-based vaccines
Funding Round
Dec 24, 2020
Chimeron Bio raised $300000 on 2020-12-24 in Angel Round
Funding Round
Jan 01, 2018
Chimeron Bio raised an undisclosed amount on 2018-01-01 in Venture Round